Fake Ozempic drugs found in US drug supply, FDA warns

As counterfeit Ozempic circulates in the US, the Food and Drug Administration has issued a warning to Americans.In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg” were in the US drug supply chain. Ozempic is an injectable medication approved to treat type 2 diabetes.Wegovy, the same drug but at a higher dose, is approved to treat obesity.“The counterfeit products were distributed outside the Novo Nordisk authorized supply chain in the US,” the FDA stated in its announcement.

“FDA seized the identified counterfeit products on April 9, 2025.”The FDA has advised patients, wholesalers, retail pharmacies and healthcare professionals to check any Ozempic products in their possession.Any medications labeled with lot number PAR0362 and with a serial number starting with the first eight digits 51746517 should not be used, sold or distributed, per the agency.“FDA is aware of six adverse event reports associated with this lot.However, none of them appear to be associated with the counterfeit product,” the statement said.

“All six adverse events were reported by Novo Nordisk.”Dave Moore, executive vice president of US operations and President of Novo Nordisk Inc., provided the below statement to Fox News Digital. “At Novo Nordisk, patient safety is our top priority, and we take the growing number of incidents involving counterfeit versions of Ozempic very seriously,” he said.“It is gravely concerning, and we do all we can to alert patients, healthcare professionals, wholesalers and retail pharmacies about counterfeit incidents when they arise.” The seized products are currently being tested by the FDA and Novo Nordisk to determine the identity, quality or safety of the drugs. The FDA’s investigation is ongoing, the agency added.Dr.Brett Osborn, a Florida neurosurgeon and longevity ...